Meet Image Analysis Group in Boston!
Are you attending IO360 in Boston? We hope to see you there! Schedule a time to chat with one of experts about how IAG can improve patient outcomes by delivering better, faster clinical trials through our Digital Data Management infrastructure DYNAMIKA, global operational team, and IO expertise.
You also don’t want to miss the panel session, “AI’s Role in Advancing Immuno-Oncology R&D Strategies,” featuring Dr. Olga Kubassova, Founder and CEO of IAG, on March 25th at 2:25 pm, to learn about how AI is transforming immuno-oncology R&D by:
• Identifying pathways and interactions in the tumor microenvironment beyond genomics
• Analyzing immune-tumor cell spatial relationships to improve immunotherapy
• Uncovering drivers of immune evasion and cancer progression
• Optimizing immune therapies like ADCs, cancer vaccines, and CAR T-cells
• Accelerating drug discovery and reshaping R&D methodologies
• Enabling strategic collaborations and transforming business models in IO